It is established that tumour hypoxia is a predictor of cancer disease progression, treatment failures, and metastatic potential. There remains a need for oxygen delivery mechanisms for hypoxia reduction. The ideal method for measuring oxygen in tissue is noninvasive and quantitative, allowing tumour pO2 measurements to be obtained before, during, and after treatment. We investigated effects of oxygen nano-carriers on the longitudinal relaxation times of tumour tissues in vivo and a phantom. T1 decreased with increased oxygen concentration in phantom. The injection of the oxygenated nanobubbles resulted in a statistically significant decrease in T1-weighted signal when measured 6-8 minutes post-injection.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords